- Home
- ARVN vs AVDX Comparison
ARVN vs AVDX Comparison
Compare ARVN & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- AVDX
- Stock Information
- Founded
- ARVN 2015
- AVDX 2000
- Country
- ARVN United States
- AVDX United States
- Employees
- ARVN N/A
- AVDX N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- AVDX EDP Services
- Sector
- ARVN Health Care
- AVDX Technology
- Exchange
- ARVN Nasdaq
- AVDX Nasdaq
- Market Cap
- ARVN 1.8B
- AVDX 1.6B
- IPO Year
- ARVN 2018
- AVDX 2021
- Fundamental
- Price
- ARVN $18.48
- AVDX $10.54
- Analyst Decision
- ARVN Strong Buy
- AVDX Hold
- Analyst Count
- ARVN 13
- AVDX 15
- Target Price
- ARVN $63.00
- AVDX $11.70
- AVG Volume (30 Days)
- ARVN 967.8K
- AVDX 1.6M
- Earning Date
- ARVN 10-30-2024
- AVDX 11-06-2024
- Dividend Yield
- ARVN N/A
- AVDX N/A
- EPS Growth
- ARVN N/A
- AVDX N/A
- EPS
- ARVN N/A
- AVDX N/A
- Revenue
- ARVN $161,100,000.00
- AVDX $427,566,000.00
- Revenue This Year
- ARVN $237.44
- AVDX $17.55
- Revenue Next Year
- ARVN N/A
- AVDX $10.57
- P/E Ratio
- ARVN N/A
- AVDX N/A
- Revenue Growth
- ARVN 1.07
- AVDX 17.84
- 52 Week Low
- ARVN $17.37
- AVDX $7.38
- 52 Week High
- ARVN $53.08
- AVDX $13.56
- Technical
- Relative Strength Index (RSI)
- ARVN 32.78
- AVDX 46.09
- Support Level
- ARVN $17.37
- AVDX $10.54
- Resistance Level
- ARVN $19.21
- AVDX $11.37
- Average True Range (ATR)
- ARVN 1.64
- AVDX 0.33
- MACD
- ARVN -0.59
- AVDX -0.18
- Stochastic Oscillator
- ARVN 11.80
- AVDX 21.32
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.